USTEKINUMAB-STBA for Colitis ulcerative: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 28 adverse event reports in the FDA FAERS database where USTEKINUMAB-STBA was used for Colitis ulcerative.
Most Reported Side Effects for USTEKINUMAB-STBA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Intentional product use issue | 46 | 25.0% | 2 | 6 |
| Off label use | 43 | 23.4% | 3 | 7 |
| Intentional dose omission | 21 | 11.4% | 1 | 9 |
| Crohn's disease | 20 | 10.9% | 1 | 5 |
| Death | 15 | 8.2% | 15 | 2 |
| Haematochezia | 13 | 7.1% | 0 | 3 |
| Condition aggravated | 12 | 6.5% | 0 | 3 |
| Diarrhoea | 10 | 5.4% | 0 | 2 |
| Colitis ulcerative | 8 | 4.4% | 0 | 1 |
| Psoriasis | 8 | 4.4% | 0 | 0 |
| Abdominal pain | 6 | 3.3% | 0 | 3 |
| Frequent bowel movements | 6 | 3.3% | 0 | 1 |
| Surgery | 6 | 3.3% | 0 | 2 |
| Symptom recurrence | 6 | 3.3% | 0 | 0 |
| Drug dose omission by device | 5 | 2.7% | 0 | 0 |
Other Indications for USTEKINUMAB-STBA
Crohn's disease (79)
Psoriasis (66)
Product used for unknown indication (13)
Psoriatic arthropathy (6)
Other Drugs Used for Colitis ulcerative
ADALIMUMAB (34,530)
VEDOLIZUMAB (33,987)
INFLIXIMAB (21,373)
INFLIXIMAB-DYYB (6,767)
TOFACITINIB (6,358)
MESALAMINE (6,347)
UPADACITINIB (4,800)
USTEKINUMAB (3,872)
GOLIMUMAB (3,637)
HUMIRA (2,707)